Joe Rancour represents clients in connection with antitrust aspects of mergers and acquisitions and antitrust litigation. Mr. Rancour has experience across a variety of industries, including semiconductors and other high technology markets, telecommunications, medical devices, life sciences, chemicals, and financial exchanges.
Examples of Mr. Rancour’s M&A representations include:
- Sprint in its proposed merger with T-Mobile;
- CME Group in its acquisition of NEX;
- Intel in its acquisition of Mobileye, sale of Wind River to TPG and spin-out of the Intel Security business (McAfee);
- NXP in its proposed acquisition by Qualcomm;
- Cardinal Health in its acquisition of Medtronic’s Patient Care, Deep Vein Thrombosis and Nutritional Insufficiency businesses;
Nokia in its acquisition of Alcatel-Lucent;
Freescale in its acquisition by NXP;
Merck KGaA in its acquisition of Sigma-Aldrich; and
Corning in its acquisition of Becton Dickinson’s Discovery Labware.
Examples of Mr. Rancour’s litigation representations include:
Sprint in its challenge to AT&T’s proposed acquisition of T-Mobile; and
Norfolk Southern Railway Co. in a multi-defendant antitrust class action.
Mr. Rancour also has represented clients in pro bono matters, including Social Security disability and estate planning.